Martin S Kunz

Structural brain signature of cognitive decline in Parkinson’s disease: DTI-based evidence from the LANDSCAPE study

D. Berg, S. Baudrexel, E. Kalbe, 2019, Therapeutic advances in neurological disorders.

Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?

H. Braak, H. Huppertz, D. Berg, 2019, Human brain mapping.

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial

C. Hartmann, S. Groiss, K. Bötzel, 2019, The Lancet Neurology.

Eye movement alterations in presymptomatic C9orf72 expansion gene carriers

D. Lulé, J. Kassubek, A. Ludolph, 2021, Journal of Neurology.

Olfactory screening of Parkinson’s Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin’ Sticks 12-identification test

Zhaoxia Wang, J. Kassubek, A. Ludolph, 2019, PloS one.